Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T19:56:17.502Z.
Calculation as of: 2026-10-06T19:56:17.502Z.
Quote observation: 2026-10-06T19:50:37.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: fc92921354a3baefe39f76a6e19d16813aeb2294e32cc7e27fab112852b36d76
PEG RATIO
N/A
Envoy Medical, Inc.
Market Cap
$50.99M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Envoy Medical, Inc. (COCH) | $50.99M | N/A |
| biote Corp. (BTMD)vs › | $50.72M | N/A |
| Tenax Therapeutics, Inc. (TENX)vs › | $50.66M | N/A |
| ImageneBio Inc (IMA)vs › | $51.43M | N/A |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $50.44M | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $51.98M | N/A |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $50.00M | N/A |
| Clene Inc. (CLNN)vs › | $49.96M | N/A |
| Precision Optics Corporation, Inc. (POCI)vs › | $49.58M | N/A |
| INmune Bio, Inc. (INMB)vs › | $49.45M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
